NCT01844531View on ClinicalTrials.gov

Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy
Interventions
DRUG

empagliflozin

single tablet empagliflozin

DRUG

metformin (Glucophage®)

single tablet metformin

DRUG

metformin (Glucophage®)

single tablet metformin

DRUG

empagliflozin

single tablet empagliflozin

DRUG

empagliflozin and metformin

FDC tablet empagliflozin and metformin

DRUG

empagliflozin and metformin

FDC tablet empagliflozin and metformin

Trial Locations (1)

Unknown

1276.6.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY